KEGG   DRUG: Midostaurin
Entry
D05029                      Drug                                   
Name
Midostaurin (JAN/USAN/INN);
Rydapt (TN)
Product
Formula
C35H30N4O4
Exact mass
570.2267
Mol weight
570.64
Structure
Simcomp
Class
Antineoplastic
 DG01918  Tyrosine kinase inhibitor
  DG01917  Receptor tyrosine kinase inhibitor
Metabolizing enzyme substrate
 DG01633  CYP3A/CYP3A4 substrate
  DG02913  CYP3A4 substrate
Remark
ATC code: L01EX10
Product: D05029<US>
Efficacy
Antineoplastic, Receptor tyrosine kinase inhibitor
  Disease
Acute myeloid leukemia (FLT3 mutation-positive) [DS:H00003]
Systemic mastocytosis [DS:H01511]
Target
FLT3* (CD135) [HSA_VAR:2322v1 2322v2] [HSA:2322] [KO:K05092]
KIT (CD117) [HSA:3815] [KO:K05091]
PDGFR [HSA:5156 5159] [KO:K04363 K05089]
VEGFR2 (KDR) [HSA:3791] [KO:K05098]
PRKCA [HSA:5578] [KO:K02677]
PRKCB [HSA:5579] [KO:K19662]
PRKCG [HSA:5582] [KO:K19663]
  Pathway
hsa04010  MAPK signaling pathway
hsa04151  PI3K-Akt signaling pathway
hsa04370  VEGF signaling pathway
hsa04670  Leukocyte transendothelial migration
hsa05200  Pathways in cancer
hsa05221  Acute myeloid leukemia
  Network
nt06275  Acute myeloid leukemia
Metabolism
Enzyme: CYP3A4 [HSA:1576]
Interaction
Structure map
map07045  Antineoplastics - protein kinase inhibitors
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01E PROTEIN KINASE INHIBITORS
    L01EX Other protein kinase inhibitors
     L01EX10 Midostaurin
      D05029  Midostaurin (JAN/USAN/INN) <US>
USP drug classification [BR:br08302]
 Antineoplastics
  Molecular Target Inhibitors
   Multitargeted Kinase Inhibitors, FLT3
    Midostaurin
     D05029  Midostaurin (JAN/USAN/INN)
Drug groups [BR:br08330]
 Antineoplastic
  DG01918  Tyrosine kinase inhibitor
   DG01917  Receptor tyrosine kinase inhibitor
    D05029  Midostaurin
 Metabolizing enzyme substrate
  DG01633  CYP3A/CYP3A4 substrate
   DG02913  CYP3A4 substrate
    D05029  Midostaurin
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Serine/threonine kinases
   AGC group
    PRKCA
     D05029  Midostaurin (JAN/USAN/INN) <US>
    PRKCB
     D05029  Midostaurin (JAN/USAN/INN) <US>
    PRKCG
     D05029  Midostaurin (JAN/USAN/INN) <US>
  Receptor tyrosine kinases (RTK)
   PDGFR family
    PDGFR
     D05029  Midostaurin (JAN/USAN/INN) <US>
    KIT (CD117)
     D05029  Midostaurin (JAN/USAN/INN) <US>
    FLT3* (CD135) [HSA_VAR:2322v1 2322v2]
     D05029  Midostaurin (JAN/USAN/INN) <US>
   VEGFR family
    VEGFR2 (KDR)
     D05029  Midostaurin (JAN/USAN/INN) <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D05029
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D05029
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D05029
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D05029
Pharmacogenomic biomarkers [br08341.html]
 Somatic variations in targeted cancer therapies
  D05029
Other DBs
CAS: 120685-11-2
PubChem: 47206756
ChEBI: 63452
PDB-CCD: 2K2[PDBj]
LigandBox: D05029
NIKKAJI: J492.319G
LinkDB
KCF data

ATOM        43
            1   C8y C    18.3242  -20.7759
            2   C8y C    18.3250  -22.1603
            3   C8y C    19.5242  -22.8517
            4   C8y C    20.7229  -22.1589
            5   C8y C    20.7221  -20.7745
            6   C8y C    19.5226  -20.0830
            7   C5x C    17.0074  -20.3488
            8   N1x N    16.1942  -21.4692
            9   C1x C    17.0087  -22.5887
            10  N4y N    21.7504  -19.8475
            11  C8y C    21.1867  -18.5831
            12  C8y C    19.8097  -18.7287
            13  C8y C    19.8129  -24.2056
            14  C8y C    21.1900  -24.3496
            15  N4y N    21.7523  -23.0845
            16  O5x O    16.5825  -19.0442
            17  C8x C    21.7489  -17.3182
            18  C8x C    20.9345  -16.1987
            19  C8x C    19.5577  -16.3442
            20  C8x C    18.9954  -17.6092
            21  C8x C    18.9999  -25.3261
            22  C8x C    19.5636  -26.5903
            23  C8x C    20.9406  -26.7343
            24  C8x C    21.7537  -25.6139
            25  C1y C    23.1429  -20.1421
            26  C1z C    23.1444  -22.7884
            27  O2x O    22.4435  -21.4950
            28  C1x C    24.5430  -20.1413
            29  C1y C    24.5445  -22.7876
            30  C1y C    25.2652  -21.4662
            31  C1a C    23.2886  -24.1489
            32  O2a O    25.2374  -23.9849
            33  N1c N    26.6718  -21.4976
            34  C1a C    24.5187  -25.2340
            35  C1a C    27.3420  -22.7208
            36  C5a C    27.4015  -20.2966
            37  C8y C    26.7238  -19.0595
            38  O5a O    28.7710  -20.3274
            39  C8x C    27.4635  -17.8425
            40  C8x C    26.7907  -16.6146
            41  C8x C    25.3910  -16.5832
            42  C8x C    24.6514  -17.8003
            43  C8x C    25.3241  -19.0281
BOND        51
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     1   7 1
            8     7   8 1
            9     8   9 1
            10    2   9 1
            11    5  10 1
            12   10  11 1
            13   11  12 1
            14    6  12 1
            15    3  13 1
            16   13  14 1
            17   14  15 1
            18    4  15 1
            19    7  16 2
            20   11  17 2
            21   17  18 1
            22   18  19 2
            23   19  20 1
            24   12  20 2
            25   13  21 2
            26   21  22 1
            27   22  23 2
            28   23  24 1
            29   14  24 2
            30   10  25 1
            31   15  26 1
            32   25  27 1
            33   27  26 1
            34   25  28 1
            35   26  29 1
            36   29  30 1
            37   28  30 1
            38   26  31 1 #Down
            39   29  32 1 #Up
            40   30  33 1 #Up
            41   32  34 1
            42   33  35 1
            43   33  36 1
            44   36  37 1
            45   36  38 2
            46   37  39 2
            47   39  40 1
            48   40  41 2
            49   41  42 1
            50   42  43 2
            51   37  43 1

» Japanese version   » Back

DBGET integrated database retrieval system